The Board of Trustees of Muscular Dystrophy UK (the operating name of the Muscular Dystrophy Group of Great Britain and Northern Ireland) presents its Annual Report and Financial Statements for the year ended 31 March 2020.
What Muscular Dystrophy UK does – core purpose and activities Our vision A world with effective treatments and cures for all muscle-wasting conditions and no limits in life for individuals and families affected.
Our mission We are the UK charity for individuals and families living with muscle-wasting conditions. •
We support research to drive the development of effective treatments and cures.
•
We ensure access to specialist NHS care and support.
•
e provide services and promote opportunities to enable individuals and their W families to live as independently as possible.
We know we can beat muscle-wasting conditions more quickly if we work together. We are uniting skills, knowledge and resources in the UK and working with others around the world so we can improve the quality of life for those affected, and bring treatments and cures closer to reality.
Our values •
We care: we care about everyone affected by muscle-wasting conditions.
•
We are inclusive: we are working to ensure there is support and treatment for everyone living with muscle-wasting conditions in the UK.
•
We are collaborative: we work in partnership across the UK, and internationally, to maximise our impact.
•
We are focused on results: everything we do is designed to improve the quality of life for individuals and families; we won’t stop until treatments and cures are found for all muscle-wasting conditions.
•
We are determined: we have been leading the fight against muscle-wasting conditions for more than 60 years and are unwavering in our commitment to unite resources and achieve our vision.
Objects of Muscular Dystrophy UK for the Public Benefit The charity is established to promote research into muscle-wasting conditions; to promote the provision of care and treatments to those affected; to assist those who care for individuals affected by such conditions; to promote education and training for affected individuals and to raise the awareness of the public on any matter relating to the charity’s objects.
Muscular Dystrophy UK Annual Report and Financial Statements for the year ended 31 March 2020
3
